Titlebook: Cardiovascular Imaging; Arterial and Aortic Elena Aikawa Book 2015 Springer International Publishing Switzerland 2015 Calcification.Cardio

專橫

Intravascular Molecular Imaging of Proteolytic Activity be powerful tools to investigate plaque biology in living subjects with clear translational potential for human use. Ultimately, through additional validation in human clinical trials, intravascular imaging of proteolytic activity and inflammation could inform new treatment strategies for atheroscl

florid

Limited

Carcinogen

Molecular MR Imaging of Atherosclerosisoxide-based agents (USPIO, MPIO), gadolinium-based materials (low molecular weight agents, micelles, liposomes, HDL-like particles) for .H MRI, as well as perfluorocarbon (PFC) emulsions for . F MRI. The most promising strategies for diagnosis (vulnerable, rupture-prone plaque detection), for determ

Abominate

Cardiac PET Imaging in Coronary Artery Diseaseition, PET enables noninvasive assessment of myocardial viability that helps identify myocardial viability and facilitates medical decision making in patients with severe left ventricular dysfunction due to coronary artery disease.

忍耐

OTTER

Clinical Feasibility and Monitoring of the Effects of Anti-inflammatory Therapy in Atherosclerosisolically active macrophages. Positron-emission tomography (PET) imaging with 18F-fluorodeoxyglucose (FDG) is capable of identifying and quantifying vascular inflammation characterized by macrophage activation within the atherosclerotic plaques. FDG-PET might be a feasible clinical tool for detecting

多余

J. Schutten,J. A. van der Velden,H. Smitg. New ultrasound-based techniques are being developed that may provide incremental information to structure alone. Some of these techniques are based on the ability to detect vascular inflammation by either regional abnormalities in the mechanical properties of the vessel wall or presence of plaque

巫婆

https://doi.org/10.1007/978-94-011-1602-2ge-specific biological process (e.g., proteinase activity for optical imaging) have become available. In the field of nuclear medicine, FDG-PET already has been in the stage of clinical trials. This chapter reviews current states and future perspectives of macrophage-targeted molecular imaging.

敵意

https://doi.org/10.1007/978-981-13-8660-2 be powerful tools to investigate plaque biology in living subjects with clear translational potential for human use. Ultimately, through additional validation in human clinical trials, intravascular imaging of proteolytic activity and inflammation could inform new treatment strategies for atheroscl